BDH Industries Limited (BDHIL), established in 1990, is a pharmaceutical company that manufactures a wide range of therapeutic drug formulations, particularly in the antibiotic, anti-inflammatory, and anti-microbial segments. The company, which went public in 1994, focuses on Oral Solid Dosages (OSD) technologies and is supported by a research and development center in Mumbai, specialized in Novel Drug Delivery Systems (NDDS).
BDHIL expanded its production facilities in the late 1990s and early 2000s, partly financed through a public issue in 1995 and term loans. The company also initiated international collaboration by entering a MoU with Nepothene Group Pvt Ltd in Nepal. Additionally, BDHIL has diversified its portfolio by commissioning wind turbines in Rajasthan and venturing into the agro-products business in 2021-22, indicating a strategic move towards sustainability and diversification.
